Physician profile
Derek Scott Watson
NPI 1699883454
$11,299.83
in general payments reported to CMS, 2019-2025
14 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $34.34 · 2021: $132 · 2022: $196 · 2024: $10K · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,226 · Travel and Lodging: $1,996 · Food and Beverage: $1,429 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,225.86 |
| Travel and Lodging | $1,996.28 |
| Food and Beverage | $1,428.89 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,261.45 | 2022-2024 | |
| Innovation Technologies INC | $171.23 | 2024 | Irrisept |
| Stryker Corporation | $151.66 | 2020-2022 | |
| Acell, INC. | $148.46 | 2019 | |
| Tela Bio, INC. | $139.62 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lemaitre Vascular, INC. | $116.18 | 2021 | |
| Conmed Corporation | $111.11 | 2025 | Airseal |
| Medtronic, INC. | $54.62 | 2025 | V-Loc 180, Ligasure |
| Osiris Therapeutics INC. | $49.98 | 2019 | |
| Integra Lifesciences Corporation | $32.62 | 2019-2021 | |
| Misonix INC | $20.96 | 2019 | |
| Csl Behring | $16.30 | 2019 | |
| Smith+Nephew, INC. | $13.86 | 2019 | |
| W. L. Gore & Associates, INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.